| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 6.52B | 6.14B | 5.44B | 4.49B | 2.67B |
| Gross Profit | 2.13B | 2.65B | 2.41B | 1.87B | 834.90M |
| EBITDA | 2.49B | 2.35B | 2.09B | 1.61B | 586.20M |
| Net Income | 1.34B | 1.25B | 1.12B | 664.40M | -142.40M |
Balance Sheet | |||||
| Total Assets | 11.47B | 11.78B | 10.80B | 11.71B | 11.18B |
| Cash, Cash Equivalents and Short-Term Investments | 986.80M | 1.13B | 1.06B | 1.99B | 1.82B |
| Total Debt | 3.19B | 3.38B | 3.31B | 4.41B | 4.98B |
| Total Liabilities | 6.62B | 6.72B | 6.31B | 7.13B | 7.44B |
| Stockholders Equity | 4.85B | 5.06B | 4.48B | 4.58B | 3.75B |
Cash Flow | |||||
| Free Cash Flow | 2.09B | 1.36B | 1.19B | 874.10M | 176.10M |
| Operating Cash Flow | 2.15B | 2.15B | 1.79B | 1.44B | 636.30M |
| Investing Cash Flow | -805.60M | -1.15B | 4.50M | -493.30M | -205.50M |
| Financing Cash Flow | -1.41B | -990.10M | -2.19B | -640.10M | -865.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | €3.23B | 10.56 | -46.16% | 3.23% | -2.79% | 0.61% | |
73 Outperform | €38.44B | 16.72 | ― | 4.09% | 9.47% | 6.30% | |
73 Outperform | €1.91B | 13.79 | 21.55% | 2.28% | 6.84% | 16.03% | |
69 Neutral | €21.17B | 27.56 | 25.78% | 2.24% | 8.08% | 11.80% | |
65 Neutral | €26.71B | 18.49 | 20.71% | 2.38% | 25.47% | 7.63% | |
61 Neutral | €338.35M | 12.32 | 32.48% | ― | 6.79% | 130.31% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |